-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ear neurostim stimulation therapy, a non-invasive neurostimation therapy that transmits mesothyli-electric neuromassion (PENFS) to the outer ear, is effective in children with functional abdominal pain disorders.
preclinical studies have shown that PENFS can reduce visceral pain allergy by regulating the central pain pathway.
therefore, this study aims to assess the efficacy of PENFS in adolescents with irrita irritatative bowel syndrome (IBS).
The researchers randomly assigned patients with IBS to a group receiving PENFS for electrostim stimulation therapy (n - 27; middle age: 15.3 years old) or false stimulation (n - 23; middle age, 15.6 years) for a total of 4 weeks five days a week.
end point was a 30 percent or more reduction in the severity of abdominal pain after 3 weeks.
secondary endpoint is a symptom relief scale after 3 weeks, which reduces the severity of abdominal pain and improves the overall symptoms.
, 59 percent of patients who received PENFS had a 30 percent or more reduction in abdominal pain, while 26 percent of patients who received false stimulation had reduced abdominal pain (P .024).
the median overall pain in patients receiving PENFS was 7.5 (IQR, 3.6-14.4), while the fake surgical group was 14.4 (IQR, 4.5-39.2) (P .026).
: Ear nerve stimulation reduced abdominal pain ear nerve stimulation in IBS patients lowered abdominal pain scores and improved overall health in IBS adolescents.
PENFS can be a non-invasive treatment option for pediatric patients with functional bowel disease.
.